Psilocybin and Psychedelics in Connecticut: Pending Legislation
This page tracks the current legal status of psilocybin, psychedelics, and entheogens in Connecticut. Status is updated from our legislation sync, with citations to the underlying bills and policy decisions.
Connecticut is advancing SB 191 to expand the psychedelic-assisted therapy pilot program, allowing eligibility for adults 18+ meeting clinical criteria. The bill builds on previous legislative efforts (SB 1083, SB 5297) and would repeal and replace the existing narrower framework with a broader therapeutic access program.
SB 191 seeks to expand psychedelic-assisted therapy pilot program eligibility Would allow adults 18+ meeting clinical eligibility criteria Builds on previous bills SB 1083 (2021) and SB 5297 (2024) Would repeal and replace existing narrower framework Focus on clinical supervised therapeutic access Growing legislative support for expanded mental health treatment options
Laws change. Always verify current status with primary sources before acting on this information, especially when traveling across state lines.